Recruiting NA Eye-tracking

New treatment option for Eye-tracking

Official title Eye-Tracking FP "A Pilot Study of the Quantitative Evaluation of the Attention Paid to Faces With Facial Palsy by the Eye-tracking Technology.

ClinicalTrials.gov ID: NCT04886245

What this study is testing

What it's testing
The facial palsy concerns between 15 and 40 people per 100000 inhabitants. They are of various etiologies such as infectious, tumoral, traumatic or idiopathic.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older. Healthy volunteers may be eligible.

You may be able to join if

  • for patient with facial paralysis:
  • Patient with peripheral facial palsy, irrespective of grade, whether or not previously treated
  • Patient providing written informed consent
  • Patient aged ≥ 18 years
  • Patient affiliated to a social security system

You likely can't join if

  • for Patient with facial paralysis:
  • Patient with recent peripheral facial palsy whose total recovery is possible
  • Patient unable to provide written informed consent
  • Patient with difficulties to follow instructions and especially to stand in front of a computer screen
  • Minor patient \<18 years
  • Patient under guardianship or curators or judicial safeguard
See the full eligibility criteria
Who can join
  • for patient with facial paralysis:
  • Patient with peripheral facial palsy, irrespective of grade, whether or not previously treated
  • Patient providing written informed consent
  • Patient aged ≥ 18 years
  • Patient affiliated to a social security system
  • for Healthy voluntary subject :
  • Subject without major facial sequelae
  • Subject who provided written informed consent
  • Major subject ≥ 18 years old
  • Subject affiliated to a social security system
What rules you out
  • for Patient with facial paralysis:
  • Patient with recent peripheral facial palsy whose total recovery is possible
  • Patient unable to provide written informed consent
  • Patient with difficulties to follow instructions and especially to stand in front of a computer screen
  • Minor patient \<18 years
  • Patient under guardianship or curators or judicial safeguard
  • for Healthy voluntary subject :
  • Subject with major facial sequelae
  • Subject not able to provide written informed consent
  • Subject presenting difficulties in following instructions and in particular in standing still in front of a computer screen
  • Minor subject \< 18 years old
  • Subject under guardianship or curators or judicial safeguard

The study team makes the final eligibility decision.

Where it's taking place

  • Amiens, France

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Amiens, France. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.